FRANKFURT, March 4 (Reuters) - Bayer's CEO (BAYGn.DE), opens new tab is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline this year, as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results